General Information
Get notified when Biodesix, Inc. moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Biodesix, Inc.
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
United States Market
Biotechnology
About Biodesix, Inc.
Taxonomy: diagnostic solutions, lung cancer, oncology, biopharma services, proteomics, genomics, liquid biopsy, biotech, lifesciences, molecular diagnostics, companion diagnostics, mass spectrometry analysis, biomarkers, clinical trials, multi-omics
Funding Rounds & Investors (15)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Post-IPO Equity | •••••• | - | 05 Apr 2024 | |
| Post-IPO Debt | •••••• | 1 |
|
16 Nov 2022 |
| Post-IPO Equity | •••••• | - | 07 Apr 2022 | |
| Post-IPO Equity | •••••• | 1 |
|
07 Mar 2022 |
| Venture Round | •••••• | - | 01 Oct 2020 |
Biodesix, Inc. Alternatives & Competitors
Delivering critical diagnostic solutions to resource-poor markets with a commitment to quality, affo...
Working together to create a healthier world, one life at a time.
Because Every Result Matters
FAQ About Biodesix, Inc.
Don't just browse. Track.
Signal Tracker monitors Biodesix, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.